1.
|
14 p, 3.0 MB |
Immunopathological Mechanisms of Bird-Related Hypersensitivity Pneumonitis
/
Sánchez-Díez, Silvia (Hospital Universitari Vall d'Hebron) ;
Cruz, María Jesús (Hospital Universitari Vall d'Hebron) ;
de Homdedeu, Miquel (Hospital Universitari Vall d'Hebron) ;
Ojanguren, Iñigo (Hospital Universitari Vall d'Hebron) ;
Romero-Mesones, Christian (Hospital Universitari Vall d'Hebron) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Muñoz Gall, Xavier (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Bird-related hypersensitivity pneumonitis (BRHP) is an interstitial lung disease induced by avian proteins. The immunopathological pathways involved in the disease are still unknown. This study assesses the cellular immune response and the cytokine pattern in a mouse model of BRHP. [...]
2023 - 10.3390/ijms24032884
International journal of molecular sciences, Vol. 24 (february 2023)
|
|
2.
|
17 p, 3.2 MB |
Peripheral and lung resident memory T cell responses against SARS-CoV-2
/
Grau Expósito, Judith (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sánchez-Gaona, Nerea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Massana, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Suppi, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Astorga-Gamaza, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Perea, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rosado Rodríguez, Joel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Falcó, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Kirkegaard, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Torrella Domingo, Adriana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Planas, Bibiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Navarro, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Suanzes, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Álvarez-Sierra, Daniel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ayora, Alfonso (Hospital Universitari Vall d'Hebron) ;
Sansano, Irene (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Esperalba, Juliana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Andrés, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Antón, Andrés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ramón y Cajal, Santiago (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Almirante Gragera, Benito (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pujol-Borrell, Ricardo (Hospital Universitari Vall d'Hebron) ;
Falcó, Vicenç (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Burgos, Joaquín (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Buzón, Maria José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Genescà Ferrer, Meritxell (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Resident memory T cells (T) positioned within the respiratory tract are probably required to limit SARS-CoV-2 spread and COVID-19. Importantly, T are mostly non-recirculating, which reduces the window of opportunity to examine these cells in the blood as they move to the lung parenchyma. [...]
2021 - 10.1038/s41467-021-23333-3
Nature communications, Vol. 12 (may 2021)
|
|
3.
|
14 p, 572.1 KB |
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
/
Frigola Rissech, Joan (Vall d'Hebron Institut d'Oncologia) ;
Navarro, Alejandro (Vall d'Hebron Institut d'Oncologia) ;
Carbonell, Caterina (Vall d'Hebron Institut d'Oncologia) ;
Callejo, Ana (Vall d'Hebron Institut d'Oncologia) ;
Iranzo, Patricia (Vall d'Hebron Institut d'Oncologia) ;
Cedrés, Susana (Vall d'Hebron Institut d'Oncologia) ;
Martinez-Marti, Alex (Vall d'Hebron Institut d'Oncologia) ;
Pardo Aranda, Nuria (Vall d'Hebron Institut d'Oncologia) ;
Saoudi-Gonzalez, Nadia (Vall d'Hebron Institut d'Oncologia) ;
Martinez, Débora (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Jiménez, José (Vall d'Hebron Institut d'Oncologia) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Mancuso, Francesco M. (Vall d'Hebron Institut d'Oncologia) ;
Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ;
Montuenga, Luis M. (Instituto de Investigación Sanitaria de Navarra) ;
Sanchez-Cespedes, Montse (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Prat, Aleix (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Vivancos, Ana (Vall d'Hebron Institut d'Oncologia) ;
Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ;
Amat, Ramon (Vall d'Hebron Institut d'Oncologia) ;
Universitat Autònoma de Barcelona
Immunotherapy has transformed advanced non-small cell lung cancer (NSCLC) treatment strategies and has led to unprecedented long-lasting responses in some patients. However, the molecular determinants driving these long-term responses remain elusive. [...]
2020 - 10.1002/1878-0261.12891
Molecular Oncology, 2020
|
|
4.
|
9 p, 559.7 KB |
Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients
/
Sesé, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Somoza, Rosa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Maestu, Inmaculada (Hospital Universitari Doctor Peset (València)) ;
Ureste, Maria Martín (Hospital Universitari Doctor Peset (València)) ;
Sánchez Hernández, Alfredo (Consorci Hospitalari Provincial de Castelló) ;
Córdoba Ortega, Juan Felipe (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Venturas, Griselda (Hospital Universitari Vall d'Hebron) ;
Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Hernandez-Losa, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Precision medicine has revolutionized the understanding and treatment of cancer by identifying subsets of patients who are amenable to specific treatments according to their molecular characteristics, as exemplified by epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). [...]
2019 - 10.1007/s40487-019-00099-9
Oncology and Therapy, Vol. 7 (august 2019) , p. 131-139
|
|
5.
|
4 p, 1018.1 KB |
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation
/
Cedrés, Susana (Hospital Universitari Vall d'Hebron) ;
Felip, Enriqueta (Universitat Autònoma de Barcelona) ;
Cruz, Cristina (Hospital Universitari Vall d'Hebron) ;
Martinez de Castro, Ana (Hospital Universitari Vall d'Hebron) ;
Pardo Aranda, Nuria (Universitat Autònoma de Barcelona) ;
Navarro, Alejandro (Universitat Autònoma de Barcelona) ;
Martinez-Marti, Alex (Universitat Autònoma de Barcelona) ;
Remon, Jordin (Vall d'Hebron Institut d'Oncologia) ;
Zeron-Medina, Jorge (Hospital Universitari Vall d'Hebron) ;
Balmaña Gelpí, Judith (Universitat Autònoma de Barcelona) ;
Llop-Guevara, Alba (Experimental Therapeutic Group) ;
Miquel, Josep M. (Vall d'Hebron Institut d'Oncologia) ;
Sansano, Irene (Pathology Department) ;
Nuciforo, Paolo (Molecular Oncology Group) ;
Mancuso, Francesco M (Cancer Genomic Group) ;
Serra, Violeta (Experimental Therapeutic Group) ;
Vivancos, Ana (Cancer Genomic Group)
Heat shock proteins (HSPs) are molecular chaperones that maintain proteins in their correct conformation to ensure stability and protect carcinoma cells from apoptosis. HSP90 inhibitors (HSP90i) block multiple targets simultaneously, and despite responses in a selected population, no HSP90i have yet been approved. [...]
2018 - 10.1093/jnci/djy012
Journal of the National Cancer Institute, Vol. 110 (february 2018) , p. 914-917
|
|
6.
|
13 p, 2.1 MB |
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma : the ROSING Study
/
Conde, Esther (Hospital Universitario HM Sanchinarro (Madrid)) ;
Hernández, Susana (Hospital Universitario HM Sanchinarro (Madrid)) ;
Martinez, Rebeca (Hospital Universitario HM Sanchinarro (Madrid)) ;
Angulo, Bárbara (Hospital Universitario HM Sanchinarro (Madrid)) ;
de Castro, Javier (Hospital Universitario La Paz (Madrid)) ;
Collazo-Lorduy, Ana (Hospital Universitario HM Sanchinarro (Madrid)) ;
Jimenez, Beatriz (Hospital Universitario HM Sanchinarro (Madrid)) ;
Muriel, Alfonso (Hospital Universitario Ramón y Cajal (Madrid)) ;
Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aranda, Ignacio (Instituto de Investigación Sanitaria y Biomédica de Alicante) ;
Massuti, Bartomeu (Instituto de Investigación Sanitaria y Biomédica de Alicante) ;
Rojo, Federico (Centro de Investigación Biomédica en Red de Cáncer) ;
Dómine Gómez, Manuel (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Garcia, Felip (Quironsalud Hospital) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ;
Mancheño, Nuria (Hospital Universitari i Politècnic La Fe (València)) ;
Juan, Óscar (Hospital Universitari i Politècnic La Fe (València)) ;
Sanz, Julián (Hospital Clínico San Carlos (Madrid)) ;
Gonzalez-Larriba, José Luis (Hospital Clínico San Carlos (Madrid)) ;
Atienza-Cuevas, Lidia (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ;
Arriola-Arellano, Esperanza (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ;
Abdulkader, Ihab (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Garcia-Gonzalez, Jorge (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Camacho, Carmen (Insular Materno-Infantil University Hospital Complex) ;
Rodríguez-Abreu, Delvys (Insular Materno-Infantil University Hospital Complex) ;
Teixidó, Cristina (Hospital Clínic i Provincial de Barcelona) ;
Reguart, Noemi (Hospital Clínic i Provincial de Barcelona) ;
Gonzalez-Piñeiro, Ana (Hospital Álvaro Cunqueiro (Vigo)) ;
Lázaro, Martín (Hospital Álvaro Cunqueiro (Vigo)) ;
Lozano, María Dolores (Clínica Universidad de Navarra) ;
Gurpide, Alfonso (Clínica Universidad de Navarra) ;
Gómez-Román, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Lopez-Brea, M. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Pijuan, Lara (Hospital del Mar (Barcelona, Catalunya)) ;
Salido, Marta (Hospital del Mar (Barcelona, Catalunya)) ;
Arriola, Edurne (Hospital del Mar (Barcelona, Catalunya)) ;
Company, Amparo (Hospital Clínic Universitari (València)) ;
Insa, Amelia (Hospital Clínic Universitari (València)) ;
Esteban-Rodriguez, Isabel (Hospital Universitario La Paz (Madrid)) ;
Saiz, Mónica (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Azkona, Eider (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Álvarez, Ramiro (Hospital Universitario Miguel Servet (Saragossa)) ;
Artal, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ;
Plaza, María Luz (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Aguiar de Sousa, Diana (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Enguita, Ana Belén (Hospital Universitario 12 de Octubre (Madrid)) ;
Benito, Amparo (Hospital Universitario Ramón y Cajal (Madrid)) ;
Paz-Ares, Luis (Hospital Universitario 12 de Octubre (Madrid)) ;
Garrido, Pilar (Centro de Investigación Biomédica en Red de Cáncer) ;
Lopez-Rios, Fernando (Hospital Universitario HM Sanchinarro (Madrid)) ;
Universitat Autònoma de Barcelona
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support the use of ROS1 immunohistochemistry (IHC) as a screening test, followed by confirmation with fluorescence in situ hybridization (FISH) or a molecular test in all positive results. [...]
2019 - 10.1016/j.jtho.2019.07.005
Journal of Thoracic Oncology, Vol. 14 Núm. 12 (december 2019) , p. 2120-2132
|
|
7.
|
20 p, 5.5 MB |
Insight into the role and regulation of gap junction genes in lung cancer and identification of nuclear Cx43 as a putative biomarker of poor prognosis
/
Aasen, Trond (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Montero, María Ángeles (Hospital Universitari Vall d'Hebron) ;
Romagosa, Cleofé (Hospital Universitari Vall d'Hebron) ;
Temprana-Salvador, Jordi (Hospital Universitari Vall d'Hebron) ;
Martinez-Marti, Alex (Hospital Universitari Vall d'Hebron) ;
Moliné, Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Hernández-Losa, J. (Centro de Investigación Biomédica en Red de Cáncer) ;
Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Direct intercellular communication, mediated by gap junctions formed by the connexin transmembrane protein family, is frequently dysregulated in cancer. Connexins have been described as tumour suppressors, but emerging evidence suggests that they can also act as tumour promoters. [...]
2019 - 10.3390/cancers11030320
Cancers, Vol. 11 Núm. 3 (march 2019) , p. 320
|
|
8.
|
9 p, 5.6 MB |
Pleuroparenchymal Fibroelastosis : a New Entity within the Spectrum of Rare Idiopathic Interstitial Pneumonias
/
Portillo, Karina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Guasch, Ignasi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Becker, Caroline (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Andreo García, Felipe (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Fernandez Figueras, Maria Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ramirez Ruz, José (Hospital Clínic i Provincial de Barcelona) ;
Martinez-Barenys, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
García-Reina, Samuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lopez de Castro, Pedro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Sansano, Irene (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Villar, A (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ruiz Manzano, J.. (Universitat Autònoma de Barcelona. Departament de Medicina)
Pleuroparenchymal fibroelastosis (PPFE) is a rare entity that has been recently included in the official American Thoracic Society/European Respiratory Society (ATS/ERS) statement in 2013 as a group of rare idiopathic interstitial pneumonias (IIPs). [...]
2015 - 10.1155/2015/810515
Case Reports in Pulmonology, Vol. 2015 (august 2015)
|
|